Status:
UNKNOWN
Management of Obstructive Colon Tumors in Istanbul
Lead Sponsor:
Istanbul Medipol University Hospital
Conditions:
Colon Cancer
Tumor Obstruction
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate the outcome of obstructive colon cancer surgery in terms of days-to-starting adjuvant therapy and quality of life.
Eligibility Criteria
Inclusion
- Acute intestinal obstruction due to colon cancer either preoperatively or intraoperatively detected
- Clinical findings of obstruction (Abdominal distention and pain, nausea or vomiting, and absence of bowel movements) confirmed by abdominal x-ray or CT
Exclusion
- Benign diseases
- Emergency surgery due to bleeding, perforation and other non-obstructive situations
- Recurrent colon tumors
- Rectal cancer
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05424939
Start Date
June 1 2022
End Date
May 31 2024
Last Update
June 21 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medipol University Bahcelievler Hospital
Istanbul, Turkey (Türkiye), 34196
2
Medipol Mega Hospital
Istanbul, Turkey (Türkiye), 34214